COMP <GO>
CRI vs WEYS // REVENUE GROWTH (YOY)
Carter's Inc. (NYSE) VS. Weyco Group Inc. (NASDAQ) • 15-METRIC TALLY: CRI 7
— WEYS 6
▲ REVENUE GROWTH (YOY) LEADER: CRI
LAST: $33.38 (+7.54%) • MKT CAP: $1.23B
revenue-growth
1.90%
LAST: $52.49 (+2.74%) • MKT CAP: $501.3M
revenue-growth
-4.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRI VS. WEYS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRI | WEYS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.40% | 43.20% | +2.20 | CRI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.30% | 16.10% | -4.80 | WEYS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.9x | 13.2x | -6.30 | CRI | /valuation <GO> |
| Free Cash Flow Yield | 5.60% | 7.08% | -1.48 | WEYS | /fcf-yield <GO> |
| Operating Margin | 5.00% | 10.60% | -5.60 | WEYS | /operating-margins <GO> |
| Net Profit Margin | 3.20% | 8.40% | -5.20 | WEYS | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 1.90% | -4.90% | +6.80 | CRI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.60% | 1.54% | +3.06 | CRI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.63 | 6.25 | -3.62 | WEYS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | CRI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.1 | 63.7 | -16.57 | WEYS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.4x | 20.2x | -7.80 | CRI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.23B | $501.3M | $724.1M | CRI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRI REV | WEYS REV | CRI GROSS % | WEYS GROSS % | CRI FCF | WEYS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.90B | $276.2M | 45.4% | 43.2% | $68.6M | $35.5M |
| FY 2024 | $2.84B | $290.3M | 48.0% | 45.3% | $242.6M | $36.3M |
| FY 2023 | $2.95B | $318.0M | — | — | $529.1M | $98.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRI // BETA —
WEYS // BETA —